July 9, 2020

Upneeq Becomes First FDA-Approved Medication for Ptosis

Read More
July 9, 2020

Tralement Approved as Source of Trace Elements for Certain Patients

Read More
July 9, 2020

Humira Biosimilar Approved, Expected to Launch in 2023

Read More
July 7, 2020

Mylan Recalls One Lot of Daptomycin for Injection

Read More
July 7, 2020

Inqovi Approved as First Oral Treatment for Certain Blood Cancers

Read More
July 6, 2020

Qwo Approved for Moderate to Severe Cellulite

Read More
July 2, 2020

Rukobia Approved to Treat Multidrug-Resistant HIV Infection

Read More
July 1, 2020

Brand Medications with Generic Alternatives Anticipated to be Approved in August

Read More
June 30, 2020

Lialda Receives New Pediatric Indication

Read More
June 30, 2020

Dojolvi Approved to Treat Group of Rare Metabolic Disorders

Read More
June 30, 2020

Bavencio Receives New Indication for Urothelial Carcinoma

Read More
June 29, 2020

FDA Approves Phesgo, a Combination of Perjeta and Herceptin for Subcutaneous Injection

Read More